SCHEMBL19737124

SCHEMBL19737124

CC(C)NC(Cc1c[nH]c2ccccc12)C(=O)O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE P12821 3/20 0.70
KDM4E B2RXH2 2/20 0.68
MAPT P10636 2/20 0.68
APAF1 O14727 1/20 0.68
POLB P06746 1/20 0.68
RECQL P46063 1/20 0.68
L3MBTL1 Q9Y468 1/20 0.68
ALOX15 P16050 1/20 0.67
ECE1 P42892 9/20 0.64
ITGB2 P05107 2/20 0.63
ICAM1 P05362 2/20 0.63
ITGAL P20701 2/20 0.63
SMN1; SMN2 Q16637 1/20 0.62
MEN1 O00255 1/20 0.60
LMNA P02545 1/20 0.60
MPO P05164 1/20 0.60
TSHR P16473 1/20 0.60
BLM P54132 1/20 0.60
PMP22 Q01453 1/20 0.60
KMT2A Q03164 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15592745 1.00 ACE (0.70) ACEKDM4EMAPTAPAF1POLB
SCHEMBL16750046 1.00 ACE (0.70) ACEKDM4EMAPTAPAF1POLB
SCHEMBL1263833 0.92 KDM4E (0.72) ACEKDM4EMAPTAPAF1POLB
SCHEMBL1263822 0.92 KDM4E (0.72) ACEKDM4EMAPTAPAF1POLB
SCHEMBL8254531 0.91 ACE (0.68) ACEKDM4EMAPTAPAF1POLB
SCHEMBL5870457 0.91 ACE (0.68) ACEKDM4EMAPTAPAF1POLB
SCHEMBL23423098 0.90 KDM4E (0.61) ACEKDM4EMAPTAPAF1POLB
SCHEMBL7201046 0.90 ACE (0.67) ACEKDM4EMAPTAPAF1POLB
SCHEMBL22800779 0.89 KDM4E (0.60) ACEKDM4EMAPTAPAF1POLB
SCHEMBL13233530 0.89 KDM4E (0.60) ACEKDM4EMAPTAPAF1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183253-A1 NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY RHODE ISLAND HOSPITAL 2023-06-15 US disclosed
US-20220204497-A1 NOVEL COMPOUND HAVING ANTICANCER ACTIVITY, AND METHOD FOR PRODUCING SAME DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) 2022-06-30 US disclosed
CN-114057738-A Synthesis method of chloroindole hydrazide 京博农化科技有限公司 2022-02-18 CN disclosed
EP-3804725-A2 NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY Rhode Island Hospital (US) 2021-04-14 EP disclosed
EP-3220914-B1 NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY RHODE ISLAND HOSPITAL (US) 2020-09-02 EP disclosed
US-20170362238-A1 NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY RHODE ISLAND HOSPITAL 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220204497-A1 NOVEL COMPOUND HAVING ANTICANCER ACTIVITY, AND METHOD FOR PRODUCING SAME TPX2, AIMP2, CDYL2 ACE 3827/4885KDM4E 2899/4885MAPT 4461/4885
US-20170362238-A1 NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY POLRMT, NT5C3B, CHMP4B ACE 3380/4885KDM4E 4004/4885MAPT 997/4885
US-20230183253-A1 NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY POLRMT, NT5C3B, CHMP4B ACE 3380/4885KDM4E 4004/4885MAPT 997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.